Cargando…
MUC16 affects the biological functions of ovarian cancer cells and induces an antitumor immune response by activating dendritic cells
BACKGROUND: Ovarian cancer is the 5(th) most common lethal gynecological malignancy with a 5-year survival rate of about 47% and a localized stage diagnosis of 15%, leading to about 125,000 global deaths each year. Therefore, it is urgent to explore novel and effective strategies for radical cure. M...
Autores principales: | Zhai, Yan, Lu, Qi, Lou, Tong, Cao, Guangming, Wang, Shuzhen, Zhang, Zhenyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7729312/ https://www.ncbi.nlm.nih.gov/pubmed/33313239 http://dx.doi.org/10.21037/atm-20-6388 |
Ejemplares similares
-
Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer
por: Jain, Shruti, et al.
Publicado: (2022) -
Therapeutic effect of dual CAR-T targeting PDL1 and MUC16 antigens on ovarian cancer cells in mice
por: Li, Tong, et al.
Publicado: (2020) -
MUC16 stimulates neutrophils to an inflammatory and immunosuppressive phenotype in ovarian cancer
por: Wu, Yuliang, et al.
Publicado: (2023) -
Oncolytic adenovirus with MUC16-BiTE shows enhanced antitumor immune response by reversing the tumor microenvironment in PDX model of ovarian cancer
por: Wang, Qiuman, et al.
Publicado: (2022) -
MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells
por: Gubbels, Jennifer AA, et al.
Publicado: (2010)